Skip to main content
. 2017 Mar 20;145(8):1708–1719. doi: 10.1017/S0950268817000541

Table 2.

Antimicrobial resistance, macrolide resistance genotype, and pilus islet (PI) carriage within individual clonal groups of serotype 19A pneumococci

CC (No. of isolates) No. (%) of isolates
Nonsusceptible to the corresponding antimicrobial MDR Macrolide resistance genotype* PI1 PI2
PEN AMX CTX ERY CLI SXT CHL TET
CC663 (14) 14 (100%) 13 (93%) 11 (79%) 14 (100%) 9 (64%) 3 (21%) 7 (50%) 6 (43%) 11 (79%) erm(B)/mef, 3 (21%); erm(B), 6 (43%); mef, 3 (21%); no erm(B)/mef, 2 (14%) 14 (100%) 0
CC230 (12) 12 (100%) 0 0 5 (42%) 2 (17%) 12 (100%) 1 (8%) 2 (17%) 5 (42%) erm(B)/mef, 2 (40%); mef, 3 (60%) 0 0
CC320 (7) 7 (100%) 7 (100%) 7 (100%) 7 (100%) 6 (86%) 7 (100%) 0 4 (57%) 7 (100%) erm(B)/mef, 6 (86%); mef, 1 (14%) 7 (100%) 7 (100%)
CC156 (7) 7 (100%) 7 (100%) 4 (57%) 1 (14%) 1 (14%) 6 (86%) 0 1 (14%) 1 (14%) erm(B), 1 7 (100%) 0
CC63 (1) 0 0 0 1 1 0 0 1 1 erm(B), 1 0 0
Singleton, 10 433(1) 1 0 0 1 1 0 0 0 1 erm(B), 1 0 0
Singleton, 10 436(1) 1 1 1 0 0 1 0 0 0 No ERY-R 1 0
PEN-S (6): CC180, ST10511 (1); singleton, ST10512 (3); group of two STs, ST5954 (1), ST10430 (1) 0 0 0 0 0 4 (67%) 0 1 (17%) 0 No ERY-R 0 0
Overall (49) 43 (88%) 28 (57%) 23 (47%) 29 (59%) 20 (41%) 33 (67%) 8 (16%) 13 (27%) 25 (51%) erm(B)/mef, 11 (38%); erm(B), 9 (31%); mef, 7 (24%); no erm(B)/mef, 2 (7%) 29 (59%) 7 (14%)

AMX, amoxicillin; CC, clonal complex; CHL, chloramphenicol; CLI, clindamycin; CTX, ceftriaxone; ERY, erythromycin; MDR, multidrug resistant; PEN, penicillin; SXT, trimethoprim/sulfamethoxazole; TET, tetracycline.

*

The percentage indicates proportions of isolates carrying a macrolide resistance determinant among ERY-resistant isolates. R, resistant.

PI, pilus islet.

PEN-S, a group of six PEN-susceptible isolates.